- Home
- CLRB vs LRFC Comparison
CLRB vs LRFC Comparison
Compare CLRB & LRFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLRB
- LRFC
- Stock Information
- Founded
- CLRB 2002
- LRFC 2013
- Country
- CLRB United States
- LRFC United States
- Employees
- CLRB N/A
- LRFC N/A
- Industry
- CLRB Biotechnology: Pharmaceutical Preparations
- LRFC Finance: Consumer Services
- Sector
- CLRB Health Care
- LRFC Finance
- Exchange
- CLRB Nasdaq
- LRFC Nasdaq
- Market Cap
- CLRB 76.0M
- LRFC 68.2M
- IPO Year
- CLRB N/A
- LRFC 2013
- Fundamental
- Price
- CLRB $1.86
- LRFC $25.30
- Analyst Decision
- CLRB Strong Buy
- LRFC
- Analyst Count
- CLRB 2
- LRFC 0
- Target Price
- CLRB $21.00
- LRFC N/A
- AVG Volume (30 Days)
- CLRB 289.0K
- LRFC 7.2K
- Earning Date
- CLRB 11-18-2024
- LRFC 11-07-2024
- Dividend Yield
- CLRB N/A
- LRFC 5.22%
- EPS Growth
- CLRB N/A
- LRFC N/A
- EPS
- CLRB N/A
- LRFC N/A
- Revenue
- CLRB N/A
- LRFC $19,936,000.00
- Revenue This Year
- CLRB N/A
- LRFC $3.13
- Revenue Next Year
- CLRB N/A
- LRFC $1.47
- P/E Ratio
- CLRB N/A
- LRFC N/A
- Revenue Growth
- CLRB N/A
- LRFC N/A
- 52 Week Low
- CLRB $1.82
- LRFC $19.82
- 52 Week High
- CLRB $4.45
- LRFC $25.74
- Technical
- Relative Strength Index (RSI)
- CLRB 30.70
- LRFC 59.48
- Support Level
- CLRB $1.97
- LRFC $24.77
- Resistance Level
- CLRB $2.18
- LRFC $25.40
- Average True Range (ATR)
- CLRB 0.10
- LRFC 0.65
- MACD
- CLRB -0.01
- LRFC -0.02
- Stochastic Oscillator
- CLRB 8.11
- LRFC 74.57
About CLRB Cellectar Biosciences Inc.
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. Its PDC therapeutic, iopofosine is a small-molecule PDC designed to provide targeted delivery of iodine-131 directly to cancer cells, while limiting exposure to healthy cells.
About LRFC Logan Ridge Finance Corporation
Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.